Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00295308
First received: February 22, 2006
Last updated: August 6, 2016
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2014
  Estimated Primary Completion Date: No date given
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):